| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |